Save the Date: SIP & STRATEGIZE: January 14, 2021; 6:00-7:30 pm (CST)
Inspired by the Service Design Report prepared by Val Lopez Torres, we are organizing an exciting evening to spur ideas, innovation, and communication between volunteers at Rein in Sarcoma! The 1.5-hour virtual event will consist of introductory games followed by interchanging break out rooms. The break out rooms will have a few discussion topic prompts which we will send out a couple of days prior to the event. We will be sending a formal invitation mid-December – we are super excited to see everyone!
-Jackson, Michelle, Val, Gina, and Katy
Nicholas Reiners, a 2019-20 Jan Maudlin Sarcoma Scholar and UMN medical student, will present the results of a pilot study on the impact of a soft tissue sarcoma (STS) Best Practice Alert (BPA) at the CTOS 2020 Virtual Annual Meeting, November 18 – 21.
This work began in 2017 as part of the Rein in Sarcoma Hallie Anne Brown education initiative in conjunction with HealthPartners/Regions Hospital, under the direction of Dr. Randy Hurley, hematologist/oncologist at Regions Hospital and Medical Director of HealthPartners’ Cancer Care Program. In addition to Nicholas, Robert Gao, Melissa Albersheim and Andy Hughes, also former sarcoma scholars, and Brandon Diessner, UMN graduate student, have contributed to the project.
Objectives of the Pilot Study:
- Retrospectively review STS cases in our HealthPartners (HP) system
- Develop an EMR BPA to prompt primary care clinicians to consider MRI evaluation of a STM based on specific criteria
- Assess primary care clinician acceptance of the BPA
- Measure the effect of the BPA on improving primary care clinician confidence in evaluating STMs
- Measure the impact of the BPA on patient care
This pilot study linked a BPA to specific ICD9-10 codes associated with STM to prompt MRI evaluation for large or enlarging, deep, or painful masses. Seventeen MRIs were completed and three malignant or potentially malignant diagnoses were identified. Clinicians found the BPA to be a useful clinical decision-making support tool, and it improved their confidence levels when evaluating STMs. A larger healthcare system-wide project is planned.
Online donating November 1st – 19th, 2020.
Help those with sarcoma cancers.
Give to the Max Day is now open through midnight Thursday, November 19, 2020. All donations to Rein in Sarcoma will be matched up to $9,000 through the generosity of the Rein in Sarcoma Miranda Mead Named Fund and the Jan Maudlin Sarcoma Scholar Fund.
Help us provide the 8th edition of our essential Rein in Sarcoma Patient Notebooks, distributed at no cost to newly diagnosed sarcoma patients.
Increase Awareness. Increase Survivors.
If you are a sarcoma survivor or someone who has lost a loved one to sarcoma cancer and would like to consider a Named Fund, please contact Melissa Davies at Rein in Sarcoma at firstname.lastname@example.org